表紙:病院向け膵臓癌診断用人工知能 (AI) :市場シェア・戦略・予測 2017年~2023年
市場調査レポート
商品コード
567988

病院向け膵臓癌診断用人工知能 (AI) :市場シェア・戦略・予測 2017年~2023年

Pancreatic Cancer Diagnostics Using Artificial Intelligence for Hospitals: Market Shares, Strategies and Forecasts, Worldwide 2017 to 2023

出版日: | 発行: WinterGreen Research, Inc. | ページ情報: 英文 75 Pages; 28 Tables & Figures | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.25円
病院向け膵臓癌診断用人工知能 (AI) :市場シェア・戦略・予測 2017年~2023年
出版日: 2017年10月20日
発行: WinterGreen Research, Inc.
ページ情報: 英文 75 Pages; 28 Tables & Figures
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の病院向け膵臓癌診断用人工知能 (AI) 市場について調査分析し、市場概要と市場ダイナミクス、市場シェアと市場予測、製品概要、技術、主要企業など、体系的な情報を提供しています。

第1章 病院向け膵臓癌診断用人工知能 (AI) :市場説明・市場ダイナミクス

  • 癌診断においてAIは飛躍的に進歩
  • 大規模データベースにおけるスキーマを発見するAIソリューションの能力

第2章 人工知能 (AI) 癌診断市場の促進因子

  • AI癌診断市場の促進因子
  • AI癌診断市場のシェア
  • 癌診断向けAI市場の予測
  • 癌統計
  • 病院向けAIの課題
  • 病院向けAIソフトウェアの価格
  • 病院向けAIの地域区分

第3章 病院向け人工知能 (AI) 製品

  • Partners HealthCare, IBM, および GE Healthcare
  • IBM Watson
  • Googleの AI 部門における子会社 DeepMind は英国の病院と提携
  • Prognos

第4章 病院向け人工知能 (AI) の研究・技術

  • Googleにおける研究
  • IBMのAI研究
  • Google および Nvidia Artificial Intelligence

第5章 病院向け人工知能 (AI) 企業

  • Alphabet / Google
  • General Electric (GE)
  • IBM
  • Prognos
  • Quest Diagnostics
  • Safeguard Scientifics

WinterGreen Researchについて

図表リスト

目次
Product Code: SH272124732

Worldwide markets are poised to achieve continuing growth as the artificial intelligence software increases diagnostic excellence, saving lives and lowering care delivery costs.

Automated cancer diagnostics are implemented with artificial intelligence. Systems are able to take a multi-disciplinary integrated approach to looking at imaging and scans. The analysis of patient records, looking for effectiveness of particular treatments is more work than a human can do, the quantity of data is too high, so the artificial intelligence is being used to do that.

Systems are making a significant difference in saving lives.

Much of the hospital artificial intelligence market is centered on improving diagnosis and treatment of cancer through the visualization provided by radiology. The systems are able to track and analyze more data, more accurately than can the humans. Radiologists receive years of training. They are among the highest paid doctors, also among the first group of physicians utilizing artificial intelligence because of the complexity of the task to be done.

According to Susan Eustis, lead author of the team that wrote the study, "Artificial intelligence expands into health care leveraging insight from radiological studies and diagnostics. Radiologists have a deluge of patient data that the artificial intelligence can manage in some ways. This contributes to earlier cancer diagnosis."

Artificial Intelligence for Hospital Cancer Diagnostics Market Forecasts

AI is set to become a sophisticated diagnostic aid, flagging images that humans should examine more closely, while leaving radiologists with more time for interacting with patients and medical staff.

Hospital artificial intelligence market shipments at $1.7 billion in 2023 are forecast to reach $11.4 billion dollars, worldwide 2023.

Table of Contents

Abstract: Approaching Pancreatic Cancer with Artificial Intelligence Diagnostics Vastly Improves Outcomes

Artificial Intelligence (AI) Cancer Diagnostics Executive Summary

  • Artificial Intelligence (AI) Cancer Diagnostics Market Driving Forces
  • Artificial Intelligence Cancer Diagnostics Market Shares:
  • Artificial Intelligence Cancer Diagnosis Market Forecasts:

1. Artificial Intelligence Cancer Diagnostics Market Description and Market Dynamics:

  • 1.1 Artificial Intelligence Very Big Breakthrough in Cancer Diagnostics
  • 1.2 Ability of AI Solutions To Discover Schemas in Large Databases

2. Artificial Intelligence (AI) Cancer Diagnostics Market Driving Forces

  • 2.1 Artificial Intelligence (AI) Cancer Diagnostics Market Driving Forces
  • 2.2 Artificial Intelligence Cancer Diagnostics Market Shares:
  • 2.3 Artificial Intelligence for Cancer Diagnostics Market Forecasts:
  • 2.4 Cancer Statistics
  • 2.5 Hospital Artificial Intelligence (AI) Challenges
  • 2.6 Hospital Artificial Intelligence Software Prices:
  • 2.7 Hospital Artificial Intelligence Regional Segments:

3. Hospital Artificial Intelligence Products:

  • 3.1 Partners HealthCare, IBM, and GE Healthcare
  • 3.2 IBM Watson
    • 3.2.1 IBM Genomic And Immunotherapy Supercomputing for Patient Management
    • 3.2.2 Mayo Clinic and IBM Watson
  • 3.3 Google's AI Subsidiary DeepMind is Partnering With Another UK hospital
  • 3.4 Prognos

4. Hospital Artificial Intelligence Research and Technology:

  • 4.1 Research at Google
  • 4.2 IBM AI Research
    • 4.2.1 Neural Representation of Sketch Drawings
  • 4.3 Google and Nvidia Artificial Intelligence

5. Hospital Artificial Intelligence Companies

  • 5.1 Alphabet / Google
    • 5.1.1 Google Artificial Intelligence Subsidiary DeepMind Healthcare Initiative
  • 5.2 General Electric (GE)
    • 5.2.1 General Electric Revenue by Segment
    • 5.2.2 GE Healthcare and Massachusetts General Artificial Intelligence
  • 5.3 IBM
    • 5.3.1 IBM Watson Genomics by Quest Diagnostics
    • 5.3.2 IBM Watson Healthcare Revenue
    • 5.3.3 IBM Watson Solutions Software Healthcare Revenue
  • 5.4 Prognos
    • 5.4.1 Coding Healthcare Datasets Full Of Unstructured Text
  • 5.5 Quest Diagnostics
    • 5.5.1 IBM Personalized Healthcare: Watson Genomics from Quest Diagnostics
    • 5.5.2 Quest Diagnostics Revenue
  • 5.6 Safeguard Scientifics Announces Second Quarter2017 Financial Results
    • 5.6.1 Safeguard Scientifics Prognos DxCloud

WinterGreen Research,

  • WinterGreen Research Methodology
  • WinterGreen Research Process
  • Market Research Study
  • WinterGreen Research Global Market Intelligence Company
  • Report Description: Hospital Artificial Intelligence Models Matter

List of Tables and Figures

  • Abstract: Approaching Pancreatic Cancer with Artificial Intelligence Diagnostics Vastly Improves Outcomes
  • Figure 1. Artificial Intelligence Cancer Diagnostics Market Shares, Software, Dollars, Worldwide,2016
  • Figure 2. Artificial Intelligence for Cancer Diagnosis Market Shipments Forecasts Dollars, Worldwide,2017-2023
  • Figure 3. Cancer Artificial Intelligence Components
  • Figure 4. Hospital Artificial Intelligence Predictive Functions
  • Figure 5. Artificial Intelligence Cancer Diagnostics (AI) Market Driving Forces
  • Figure 6. Healthcare Safety Features Implemented by Artificial Intelligence (AI)16
  • Figure 7. Artificial Intelligence Cancer Diagnostics Market Shares, Software, Dollars, Worldwide,2016
  • Figure 8. Artificial Intelligence for Cancer Diagnostics Market Shares, Dollars, Worldwide,2016
  • Figure 9. Artificial Intelligence for Cancer Diagnostics Market Shipments Forecasts Dollars, Worldwide,2017-2023
  • Figure 10. Artificial Intelligence for Cancer Diagnostics Market Shipments Forecasts Dollars, Worldwide,2017-2023
  • Figure 11. AI Replacements for Supervised Manual Techniques For Diagnosis And Care Delivery.
  • Figure 12. Hospital Artificial Intelligence Long-Term Goal
  • Figure 13. Hospital Artificial intelligence Action Functions
  • Figure 14. Pancreatic Cancer Survival Rate
  • Figure 15. Hospital Artificial Intelligence (AI) Challenges
  • Figure 16. Hospital Artificial Intelligence (AI) Human Factors
  • Figure 17. Hospital Artificial Intelligence Software, US and Worldwide, Shipments Forecast, Dollars, Worldwide,2017-2019
  • Figure 18. Hospital Artificial Intelligence Regional Market Segments,2016
  • Figure 19. Hospital Artificial Intelligence Regional Market Segments,2016
  • Figure 20. Truven Health Analytics Products
  • Figure 21. IBM TrueNorth Neurosynaptic System
  • Figure 22. AI Makes Words Manageable
  • Figure 23. GE Healthcare and Massachusetts General Artificial Intelligence Healthcare Initiative Workflow
  • Figure 24. GE Healthcare and Massachusetts General Artificial Intelligence Healthcare Initiative Center of Excellence
  • Figure 25. Prognos Investors
  • Figure 26. Percent Patients with Abnormally High Test5 years Prior to First Pancreatic Cancer Diagnosis Stratified by Test and by Year
  • Figure 27. Prognos Pancreatic Cancer Diagnosis Test Result Variance
  • Figure 28. Watson Genomics from Quest Diagnostics Features: